modum.io sensor devices record environmental conditions while physical products are in transit. When a change in ownership occurs, the collected data is checked against a specific smart contract in the blockchain. This contract validates that the transaction meets all of the standards set out by the sender, their clients, or the regulator and triggers various actions: notifications to sender and receiver, release of goods, payment, etc.
In this Remedy Resource pack, Pharma Logistics IQ presents a few measures to apply to bolster audit readiness within temperature controlled logistics.
To add to the discussion on continuous improvement within temperature controlled logistics, Cold Chain examines the notion of planning with a few key experts, more specifically in the areas of stability budgets, supply chain integration, temperature control with high value products, ambient ranges and oncoming trends to account for.
Cold chain partnerships are largely a matter of trust. Once cargo is handed to a forwarder or carrier, shippers must rely on their partners to safely steward their temperature-sensitive products through the cold chain. Effective, reliable partners should show low levels of wasted product from supply chain errors, because a tested and refined process best controls temperature fluctuations. We enlisted insight from; Guy Hoskens, Clinical Supply Chain Logistics Expert, Janssen, Alan Kennedy, Founder, Team-up Global and Luiz Barberini, Operations Manager- External Manufacturing Latin America Head, Bayer to examine some key collaboration mistakes that could trigger a break in a cold chain.
Multiple factors affect the decision to choose a particular mode of transport for pharmaceuticals. On the back of feedback received on the topic of air freight vs sea freight, Pharma IQ interviewed two industry experts about their thoughts on the continuing importance of air freight in the transportation of temperature controlled pharmaceuticals.
Temperature control containers are vital to protecting the stability of life‑saving medicines during transit. When comparing models, many firms struggle to determine which packages they should invest in; due to the lack of standardisation in qualification testing conducted by the manufacturers. The existing guidance on qualification testing is helpful, but the number of different thermal profiles and testing procedures used in the market (regarding product loads, preconditioning requirements, etc.), can create confusion when trying to directly compare containers. Selecting the wrong container would be a significant waste of investment and risk the safety of high-value drugs as they travel through challenging climates. To assist with the navigation of this problematic landscape, this infographic provides insight on how to keep costs low and quality high when validating and qualifying temperature control containers.
Maintaining GDP compliance whilst ensuring cost efficiency throughout the supply chain can often be challenging; selecting the right partners and solutions, and managing them effectively, is critical in order to avoid unnecessary expenditure from the planning stages right through to the last mile.
With insights from over 50 TCL industry professionals, this report will allow you to compare what your peers think about:
- Which areas of the supply chain are the least cost effective
- The most important considerations when selecting supply chain partners
- What new technologies have the potential to uncover efficiencies in supply chain management
Ahead of his participation in the Temperature Controlled Logistics Summit 2019, Pharma IQ spoke exclusively to Saddam Huq, Global QA Senior Manager, Distribution & Cold Chain, GSK Vaccines about temperature excursions on a global scale and managing the risks associated with different regions, freight types and the challenges of data management.
The future of the pharma logistics sector will be characterised by solutions that are software driven rather than hardware driven. In this article, with insights from Amy Shortman, Founder and CEO of ASC Associates Ltd we will explore how the latest technologies will affect the sector, including:
• How new technologies will bridge communication between all parties and stakeholders in the supply chain
• What real time and predictive software systems mean for temperature excursion management
• How IoT and blockchain will shape a touchless, wireless, and secure logistics operation offering an ‘immutable level of traceability’ for products
The last mile presents unique challenges for maintaining drug quality and integrity, both in terms of inaccurate planning and a lack of integration between internal systems. In this article, with insights from Henry Moran Chief Operating Officer, ASC Associates Ltd, we explore:
- Who is responsible for the last mile?
- How can you mitigate the two most common causes of disruption in the last mile?
- How will Internet of Things (IoT) shake things up in the last mile?
In this case study, DataLong16 outlines how the DL16 – Pharma solution helps to control and monitor that the cold chain has not been broken at any time from the pharmaceutical companies to the end user.
Peli BioThermal, the global name in temperature controlled packaging, exhibited its latest shipper systems and services at the 17th Annual Cool Chain Temperature Controlled Logistics conference in 2018. The products being exhibited at the annual European event provided vital protection for pharmaceutical and life sciences payloads being transported globally, including the Crēdo™ Cargo. It is the flagship temperature controlled container available from Peli BioThermal’s Crēdo™ on Demand rental program.
Take a look at the full 2018 press release now.